Lin P L, Liu C C, Fan S Z, Chao A, Shin S C, Tai Y T
Department of Anesthesiology, National Taiwan University Hospital, R.O.C.
Acta Anaesthesiol Sin. 1997 Sep;35(3):127-31.
Rocuronium is a new nondepolarizing muscle relaxant. It features a rapid onset and lack of histamine release: It has an intermediate onset of action as vecuronium. The purpose of this study was to compare the neuromuscular action and condition of intubation after a bolus dose of rocuronium or vecuronium (2 x ED90). We also compared the duration of relaxation after intubation and maintenance doses of each drug.
Sixty male or female patients, age 18-65, scheduled for elective surgery under general anesthesia were divided randomly into two groups (rocuronium and vecuronium group). All patients were ASA class I-II and pre-operative laboratory data were normal. Anesthesia was performed with fentanyl, isoflurane and O2. Rocuronium 0.6 mg/kg (2 x ED90) or vecuronium 0.1 mg/kg (2 x ED90) was given during induction of anesthesia. The response of adductor pollicis was measured with acceleromyography. Neuromuscular block was maintained by bolus injection of rocuronium 0.15 mg/kg or vecuronium 0.025 mg/kg when T1 reached 25% of control. Onset time, duration, recovery indices, intubation condition and T4/T1 ratio to 70% were recorded. Side effects were recorded during the study.
The onset time was significantly longer in vecuronium group than that of rocuronium group (102.8 +/- 26.9 s vs. 54.9 +/- 10.9 s, p < 0.05). The clinical durations of action were respectively 44.2 +/- 13.2 min in rocuronium group and 42.5 +/- 9.1 min in vecuronium group (T1 to 25%). The duration of the maintenance were respectively 28.8 +/- 9.5 min in rocuronium group and 26.1 +/- 6.8 min in vecuronium group (T1 to 25%). No adverse effect occurred with either drug. The intubation condition was similar in both groups.
We conclude that rocuronium provides a more rapid onset of action than that of vecuronium. Rocuronium is an intermediate-acting muscle relaxant as vecuronium with good to excellent intubation condition. It may be an useful alternative to vecuronium for rapid tracheal intubation.
罗库溴铵是一种新型非去极化肌松药。其特点是起效迅速且不释放组胺,作用起效时间与维库溴铵相当,属于中效。本研究旨在比较单次给予罗库溴铵或维库溴铵(2倍ED90)后的神经肌肉作用及插管条件,同时比较插管后及维持剂量下每种药物的肌松持续时间。
将60例年龄在18 - 65岁、计划在全身麻醉下进行择期手术的男性或女性患者随机分为两组(罗库溴铵组和维库溴铵组)。所有患者ASA分级为I - II级,术前实验室检查数据正常。采用芬太尼、异氟烷和氧气进行麻醉。在麻醉诱导期间给予罗库溴铵0.6mg/kg(2倍ED90)或维库溴铵0.1mg/kg(2倍ED90)。用加速度肌电图测量拇内收肌的反应。当T1降至对照值的25%时,通过静脉推注罗库溴铵0.15mg/kg或维库溴铵0.025mg/kg维持神经肌肉阻滞。记录起效时间、持续时间、恢复指数、插管条件以及T4/T1比值恢复至70%的时间。研究期间记录副作用。
维库溴铵组的起效时间显著长于罗库溴铵组(102.8±26.9秒对54.9±10.9秒,p<0.05)。罗库溴铵组的临床作用持续时间(T1至25%)分别为44.2±13.2分钟,维库溴铵组为42.5±9.1分钟。维持时间罗库溴铵组分别为28.8±9.5分钟,维库溴铵组为26.1±6.8分钟(T1至25%)。两种药物均未出现不良反应。两组的插管条件相似。
我们得出结论,罗库溴铵的起效时间比维库溴铵更快。罗库溴铵与维库溴铵一样是中效肌松药,插管条件良好至极佳。它可能是维库溴铵用于快速气管插管的有用替代药物。